Homocystinuria, a condition associated with decreased hepatic cystathionine synthetase activity (Mudd, Finkelstein, Irreverre, and Laster, 1964) , is characterized by increased urinary homocystine and methionine, by increased serum methionine levels, and by low cystathionine levels in brain (Gerritsen and Waisman, 1964b) . It is not known how these biochemical findings are related to the multiple clinical manifestations, including ectopia lentis, thromboembolism, bone changes, and mental retardation, but the inference from similar inborn biochemical errors is that symptomatic amelioration might follow the return of the amino acid homeostasis to normal. Since the metabolic role of cystathionine is not yet established, and since it is both expensive and rapidly cleared by the kidney, it seemed most appropriate in this study to evaluate possible methods of lowering serum methionine in these patients as the principal objective of treatment.
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Methods
The effects on serum methionine were studied following the separate administration of pyridoxine (50 mg., i.m., twice a day), serine (2 g., orally, twice a day), and penicillamine (100 mg./kg., orally) as well as of a low methionine diet. Each of the first four agents was given sequentially for one week to three patients. 24-hour urines and fasting bloods were obtained on several occasions before therapy and on the fifth and sixth day of each regimen; on the seventh day, an oral L-methionine tolerance test (100 mg./kg.) was performed. Similar methionine loads were given to 12 family members, including all 4 parents, and to 8 normal subjects as well.
Serum specimens were deproteinized with 70 mg./ml. sulphosalicylic acid and urine aliquots were brought to pH 20 with concentrated HC1. Samples were analysed for methionine and homocystine using a high sensitivity modification of the Beckman!Spinco amino acid analyser (O'Brien and Simmonds, 1966) . Since the early results showed no significant changes in other amino acids in plasma or urine, elution was accelerated by using only the 0 -2M pH 4 -26 acetate buffer.
Platelet adhesiveness was measured in duplicate by a slight modification on the Hellem technique (Hellem, 1960) . Aggregation of platelets was produced by adding Received January 30, 1967. ADP or collagen suspension to platelet rich plasma (Born and Cross, 1963) .
Cases Studied Five homocystinuric patients from two apparently unrelated Spanish-American families have been studied. The clinical findings are outlined in Table I. R.M. was found to have homocystinuria during screening by paper chromatography (O'Brien, 1965) and urine nitroprusside (Brand, Harris, and Biloon, 1930) testing of the mentally retarded patients in an institution in Colorado. She was one of two patients with homocystinuria detected among 1700 subjects examined in this manner. A.M. and O.M. were then discovered during family studies. O.M. was moderately retarded and has been in an institution, though she was now at home. A.M. at age 18 months was not yet crawling, walking, or speaking single words, and he was described by his mother as developing in the same manner as his two affected sisters. Three other sibs had negative urinary nitroprusside tests and were of normal intelligence. Tables II and III. Methionine levels are not shown for C.P. on penicillamine because of a skin reaction to the drug, necessitating its withdrawal. Only the methioninerestricted diet lowered serum methionine.
Methionine tolerance tests were performed on 12 unaffected members of the 2 families and also on 8 normal subjects. It can be seen from Fig. 2 that the two-hour serum methionine concentrations were higher inall four parents, than in the control patients. With such small numbers, only a very tentative discrimination of the heterozygote can be achieved. It is of interest, nevertheless, to examine the distribution of the two-hour serum methionine levels of the other family members around the .5 critical point at which the relative deviation of parents and normals is equal. In both family M and family P, one unaffected sib appears to be normal, and one a carrier. In family P, however, both paternal grandparents appeared to be heterozygotes ( Fig. 1) , as did the maternal grandmother. The maternal grandfather was apparently not a carrier, an unexpected finding in view of the distant consanguinity of the parents.
Patient P.P. had increased platelet adhesiveness and aggregation on one occasion, but on retesting on three occasions, had normal results. The other 4 patients with homocystinuria, and the 9 close family members had normal values. Discussion Homocystinuria was initially described in 1962 (Carson and Neill, 1962) and in the following four Dunn, Perry and Dolman, 1966) .
The frequency of the disease remains uncertain, but it is becoming more accurately known as the understanding of the phenotype evolves. Initial case reports included only patients with mental retardation, but a recent study of patients with dislocated lenses (Schimke et al., 1965) indicated that normal intelligence might be present. Three of the present group of patients, P.P., C.P., and A.M., are the first untreated patients described without dislocated lenses, confirmed on slit-lamp examination. The 5 patients included in this report are also the first cases of Spanish-American heritage. Fine hair was not a reliable characteristic in these patients. Nevertheless, they all demonstrated genu valgum and pes cavus, and 3 of them had prominent pectus carinatum. The odour on the breath and body ofpatient P.P. was similar to that ofmethionine. All the patients in this report were developing slowly intellectually. In this respect, A.M., aged 18 months, was following a similar pattern to his two older retarded sibs. C.P., aged 3 years, also showed delayed development, similar to her older sister, P.P. Fig. 3 demonstrates the metabolic defect in homocystinuria. It can be seen that pyridoxine is required by the defective enzyme, cystathionine synthetase, in order to form cystathionine from serine and homocysteine. Three approaches toward lowering blood methionine levels were considered. The first involved an attempt to increase cystathionine synthetase activity, initially through maximal supplementation of pyridoxine co-factor, and then by supplying increased quantities of the co-substrate serine. Pyridoxal phosphate has been shown to decrease cystathionine excretion in cystathioninuria (Frimpter, Haymovitz, and Hor- with, 1963), even though it did not restore cystathionine synthetase activity when added to liver biopsy samples from patients with homocystinuria (Mudd et al., 1964) . A previous report (Gerritsen and Waisman, 1964a ) described a decreased urinary excretion of homocysteine in one patient when given a load of methionine with 1 g. L-serine, compared to when methionine was given alone. In these patients, however, fasting serum methionine concentrations (Table II) and methionine tolerance (Table III) (Hooft, Carton, and Samyn, 1967) may be remarkably effective in some cases.
The second approach to therapy was directed at lowering the serum methionine concentration through removal of homocysteine as the disulfide complexes of cysteine and penicillamine. Cystine has been given as a supplemental amino acid to a 5-year-old homocystinuric girl with no apparent clinical benefit, though serum methionine levels were not reported (Carson et al., 1965) . Penicillamine forms a stable disulphide complex with homocysteine, as well as with cysteine (Milne, 1964) and has been used in the treatment of cystinosis (Clayton and Patrick, 1961) and to decrease urinary cystine excretion as such in patients with cystinuria (Crawhall, Scowen, and Watts, 1963) . In the present group, treatment with cysteine or penicillamine resulted in a decrease in urinary homocysteine, which was accompanied by a corresponding increase in the urinary disulfide. No changes in urine or serum methionine concentrations were observed (Tables II and III) .
The final approach to therapy, and the only successful method of decreasing serum methionine concentrations, was by means of a low methionine intake. This methionine exchange diet, outlined as exchange tables in Appendix I, includes foods for which methionine content could be found in the literature (Recommended Dietary Allowances, 1964; Bowes and Church, 1963) , or in which it was derived empirically from the protein content. It can be seen that serum methionine concentrations were maintained at substantially reduced levels in patients A.M. and C.P. while on 15-20 mg. methionine/kg. day. A.M. has now been treated uneventfully for seven months, during which time he has maintained fasting serum methionine levels of between 0 07 and 0 )21 ,umole/ml. while accelerating his rate of motor-social development. As an index of over-all adequate nutrition, his height and weight have continued at the 50th centile for his age during treatment. Serum methionine concentrations were reduced in patient P.P. while in the hospital, but, due to social factors, could not be maintained at home. The number of servings from each exchange list and the quantity of Sobee* milk can be adjusted for the individual patient, as shown for A.M. in detail in Appendix II. Although Sobee is the formula lowest in methionine content, a milk substrate with an even lower methionine concentration is needed, especially in the first months of life, and would allow increased variability in diet with increasing age. Patients P.P. and C.P. were initially treated with a very low protein diet and serum methionine concentration decreased to normal levels (< 0 04 ,tmole/ml.). Large rises in serum methionine concentrations were then seen, as well as an increase in liver alkaline phosphatase, SGOT, and LHD in patient P.P. These changes were probably related to nutritional deprivation, and have been described as a complication of low protein intake in phenylketonuria (Umbarger, 1960) . The present diets provide an adequate intake of essential amino acids, and gains in height and weight have continued in all three patients. The dietary intake of iron, calcium, and B-complex vitamins does not meet recommended levels, and these must be added as supplements. Patients are also given added cysteine, 1 g., orally, twice a day, as it cannot be synthesized from homocysteine in these patients and presumably becomes an essential amino acid. * Registered trade name.
It is of special interest to compare this experience with those of Komrower, Lambert, Cusworth, and Westall (1966) and Perry, Dunn, Hansen, MacDougall, and Warrington (1966) . Together, these three studies show that serum methionine levels can be sustained in infancy and early childhood at normal or near normal levels by a low methionine diet. Both the gelatine base supplemented with amino acids and the soya base regimen seem to be acceptable and nutritionally satisfactory. The former is more costly, more difficult to dispense, and thus less practical if larger numbers are to be treated; at the same time, it appears to afford somewhat better control in terms of serum methionine levels. In a syndrome which, like hyperphenylalaninaemia, may reflect a spectrum of enzymatic changes, it is still important to remember, however, that the relation between a high serum methionine and the development of clinical manifestations is not yet affirmed. Whether all cases will require dietary control and whether treatment is required in early infancy, as well as the duration of treatment and the critical levels of serum methionine, are questions still to be solved.
In the meantime, it seems reasonable to start treatment with a low methionine diet in infancy if older sibs with the disease are retarded or at any time in infancy or early childhood if development is impaired at the first visit, or becomes impaired during supervision. Summary This study shows that a substantial reduction in serum methionine levels in homocystinuria may be achieved by a low methionine diet, but not by the administration of pyridoxine, serine, cysteine, or penicillamine.
Details of a simple, workable low methionine exchange diet have been evolved and are presented for the first time. 
